Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $350,681 - $442,792
1,654 New
1,654 $356,000
Q3 2023

Feb 22, 2024

BUY
$253.3 - $285.89 $2.24 Million - $2.52 Million
8,832 Added 482.1%
10,664 $2.74 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $3.03 Million - $3.42 Million
11,965 Added 401.51%
14,945 $3.84 Million
Q2 2023

Feb 22, 2024

BUY
$275.25 - $318.06 $504,258 - $582,685
1,832 New
1,832 $521,000
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $820,245 - $947,818
2,980 New
2,980 $848,000
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $986,535 - $1.2 Million
3,908 Added 93.81%
8,074 $2.24 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $811,078 - $1.12 Million
4,166 New
4,166 $1.11 Million
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $1.09 Million - $1.3 Million
-5,817 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $1.13 Million - $1.42 Million
5,817 New
5,817 $1.23 Million
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $558,680 - $717,986
-2,495 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$282.99 - $369.05 $1.39 Million - $1.82 Million
-4,922 Reduced 66.36%
2,495 $706,000
Q2 2021

Aug 06, 2021

BUY
$259.0 - $414.71 $1.92 Million - $3.08 Million
7,417 New
7,417 $2.57 Million
Q1 2021

May 13, 2021

SELL
$242.95 - $284.63 $507,765 - $594,876
-2,090 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$236.26 - $355.63 $493,783 - $743,266
2,090 New
2,090 $512,000
Q3 2020

Nov 12, 2020

SELL
$264.77 - $305.71 $1.75 Million - $2.02 Million
-6,604 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$258.66 - $342.55 $1.71 Million - $2.26 Million
6,604 New
6,604 $1.77 Million
Q1 2020

May 11, 2020

SELL
$268.85 - $341.04 $890,700 - $1.13 Million
-3,313 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$220.06 - $304.07 $292,459 - $404,109
-1,329 Reduced 28.63%
3,313 $983,000
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $1.01 Million - $1.13 Million
4,642 New
4,642 $1.08 Million
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $1.02 Million - $1.33 Million
-3,468 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $65,925 - $78,568
-256 Reduced 6.87%
3,468 $1.01 Million
Q1 2018

May 11, 2018

BUY
$260.13 - $367.91 $213,046 - $301,318
819 Added 28.19%
3,724 $1.02 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $893,694 - $1 Million
2,905
2,905 $925,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.